This content is machine translated PARTNER II study Data after one year are very promising At the TCT (Transcatheter Cardiovascular Therapeutics) meeting in San Francisco, 1-year data from the PARTNER II trial were presented. Transcatheter aortic valve implantation (TAVI) shows excellent results in high-risk and…
